Salter; Rhys
Patent Applications and Registrations
Patent applications and USPTO patent grants for Salter; Rhys.The latest application filed is for "macrocyclic compounds and methods of use thereof".
Company Profile
21.29.39
- Salter; Rhys - Doylestown PA
- Salter; Rhys - Basel CH
Patent Activity
| Patent | Date |
|---|---|
| Macrocyclic Compounds And Methods Of Use Thereof App 20220143231 - Salter; Rhys ; et al. | 2022-05-12 |
| Antibodies to olanzapine haptens and use thereof Grant 11,226,345 - Hryhorenko , et al. January 18, 2 | 2022-01-18 |
| Substituted pyridine derivatives useful as C-FMS kinase inhibitors Grant 11,214,566 - Chen , et al. January 4, 2 | 2022-01-04 |
| Antibodies to aripiprazole haptens and use thereof Grant 11,105,793 - Hryhorenko , et al. August 31, 2 | 2021-08-31 |
| Antibodies to quetiapine and use thereof Grant 11,104,742 - Hryhorenko , et al. August 31, 2 | 2021-08-31 |
| Antibodies to olanzapine and use thereof Grant 11,046,786 - Hryhorenko , et al. June 29, 2 | 2021-06-29 |
| Radiolabeling Of Polypeptides App 20210017099 - Dudkin; Vadim ; et al. | 2021-01-21 |
| Antibodies To Quetiapine Haptens And Use Thereof App 20210017294 - HRYHORENKO; Eric ; et al. | 2021-01-21 |
| Substituted Pyridine Derivatives Useful As C-FMS Kinase Inhibitors App 20200399254 - Chen; Jie ; et al. | 2020-12-24 |
| Macrocyclic Chelators and Methods of Use Thereof App 20200353105 - Salter; Rhys ; et al. | 2020-11-12 |
| Antibodies to aripiprazole and use thereof Grant 10,816,561 - Hryhorenko , et al. October 27, 2 | 2020-10-27 |
| Substituted pyridine derivatives useful as C-FMS kinase inhibitors Grant 10,800,764 - Chen , et al. October 13, 2 | 2020-10-13 |
| Antibodies to olanzapine haptens and use thereof Grant 10,712,353 - Hryhorenko , et al. | 2020-07-14 |
| Antibodies To Quetiapine Haptens And Use Thereof App 20200040107 - HRYHORENKO; Eric ; et al. | 2020-02-06 |
| Antibodies To Quetiapine And Use Thereof App 20200002438 - Hryhorenko; Eric ; et al. | 2020-01-02 |
| Antibodies to aripiprazole haptens and use thereof Grant 10,488,401 - Hryhorenko , et al. Nov | 2019-11-26 |
| Antibodies to quetiapine haptens and use thereof Grant 10,465,013 - Hryhorenko , et al. No | 2019-11-05 |
| Antibodies to Aripiprazole Haptens and Use Thereof App 20190331663 - Hryhorenko; Eric ; et al. | 2019-10-31 |
| Antibodies To Olanzapine And Use Thereof App 20190315885 - Hryhorenko; Eric ; et al. | 2019-10-17 |
| Antibodies to quetiapine and use thereof Grant 10,435,478 - Hryhorenko , et al. O | 2019-10-08 |
| Antibodies To Quetiapine And Use Thereof App 20190271712 - Hryhorenko; Eric ; et al. | 2019-09-05 |
| Antibodies to aripiprazole haptens and use thereof Grant 10,379,105 - Hryhorenko , et al. A | 2019-08-13 |
| Antibodies to olanzapine and use thereof Grant 10,344,098 - Hryhorenko , et al. July 9, 2 | 2019-07-09 |
| Antibodies to quetiapine and use thereof Grant 10,288,631 - Hryhorenko , et al. | 2019-05-14 |
| Antibodies To Aripiprazole And Use Thereof App 20190128904 - Hryhorenko; Eric ; et al. | 2019-05-02 |
| Antibodies to aripiprazole and use thereof Grant 10,175,257 - Hryhorenko , et al. J | 2019-01-08 |
| Haptens of aripiprazole Grant 10,166,296 - Lin , et al. J | 2019-01-01 |
| Substituted Pyridine Derivatives Useful As C-FMS Kinase Inhibitors App 20180346454 - CHEN; Jie ; et al. | 2018-12-06 |
| Substituted pyridine derivatives useful as c-fms kinase inhibitors Grant 10,071,991 - Chen , et al. September 11, 2 | 2018-09-11 |
| Antibodies To Aripiprazole Haptens And Use Thereof App 20180149637 - Hryhorenko; Eric ; et al. | 2018-05-31 |
| Haptens Of Aripiprazole App 20180117169 - Lin; Ronghui ; et al. | 2018-05-03 |
| Antibodies To Quetiapine Haptens And Use Thereof App 20180105606 - Hryhorenko; Eric ; et al. | 2018-04-19 |
| Antibodies to quetiapine haptens and use thereof Grant 9,850,318 - Hryhorenko , et al. December 26, 2 | 2017-12-26 |
| Antibodies To Olanzapine Haptens And Use Thereof App 20170343569 - Hryhorenko; Eric ; et al. | 2017-11-30 |
| Haptens of aripiprazole Grant 9,795,685 - Lin , et al. October 24, 2 | 2017-10-24 |
| Antibodies To Olanzapine Haptens And Use Thereof App 20170240653 - Hyrhorenko; Eric ; et al. | 2017-08-24 |
| Antibodies to Aripiprazole Haptens and Use Thereof App 20170204198 - Hryhorenko; Eric ; et al. | 2017-07-20 |
| Antibodies To Quetiapine And Use Thereof App 20170176474 - Hryhorenko; Eric ; et al. | 2017-06-22 |
| Substituted Pyridine Derivatives Useful As C-fms Kinase Inhibitors App 20170158678 - CHEN; Jie ; et al. | 2017-06-08 |
| Antibodies to aripiprazole haptens and use thereof Grant 9,611,332 - Hryhorenko , et al. April 4, 2 | 2017-04-04 |
| Substituted pyridine derivatives useful as C-FMS kinase inhibitors Grant 9,611,259 - Chen , et al. April 4, 2 | 2017-04-04 |
| Haptens Of Aripiprazole App 20170072061 - Lin; Ronghui ; et al. | 2017-03-16 |
| Antibodies To Olanzapine And Use Thereof App 20170037152 - Hryhorenko; Eric ; et al. | 2017-02-09 |
| Antibodies To Aripiprazole And Use Thereof App 20170030936 - Hryhorenko; Eric ; et al. | 2017-02-02 |
| Haptens of aripiprazole Grant 9,504,682 - Lin , et al. November 29, 2 | 2016-11-29 |
| Antibodies To Quetiapine And Use Thereof App 20160341749 - Hryhorenko; Eric ; et al. | 2016-11-24 |
| Antibodies to olanzapine and use thereof Grant 9,494,608 - Hryhorenko , et al. November 15, 2 | 2016-11-15 |
| Antibodies to aripiprazole and use thereof Grant 9,494,607 - Hryhorenko , et al. November 15, 2 | 2016-11-15 |
| Antibodies to quetiapine and use thereof Grant 9,410,972 - Hryhorenko , et al. August 9, 2 | 2016-08-09 |
| Haptens of olanzapine Grant 9,303,041 - Donahue , et al. April 5, 2 | 2016-04-05 |
| Haptens of quetiapine Grant 9,304,126 - Donahue , et al. April 5, 2 | 2016-04-05 |
| Substituted Pyridine Derivatives Useful As C-fms Kinase Inhibitors App 20160016942 - CHEN; Jie ; et al. | 2016-01-21 |
| Haptens Of Quetiapine App 20140221616 - DONAHUE; Matthew Garrett ; et al. | 2014-08-07 |
| Haptens Of Olanzipine App 20140213766 - DONAHUE; Matthew Garrett ; et al. | 2014-07-31 |
| Haptens Of Aripiprazole App 20140163206 - LIN; Ronghui ; et al. | 2014-06-12 |
| Antibodies to Olanzapine Haptens and Use Thereof App 20140057303 - Hryhorenko; Eric ; et al. | 2014-02-27 |
| Antibodies to Quetiapine Haptens and Use Thereof App 20140057305 - Hryhorenko; Eric ; et al. | 2014-02-27 |
| Antibodies to Aripiprazole Haptens and Use Thereof App 20140057299 - Hryhorenko; Eric ; et al. | 2014-02-27 |
| Antibodies to Aripiprazole and Use Thereof App 20140057300 - Hryhorenko; Eric ; et al. | 2014-02-27 |
| Antibodies to Olanzapine and Use Thereof App 20140057304 - Hryhorenko; Eric ; et al. | 2014-02-27 |
| Antibodies to Quetiapine and Use Thereof App 20140057306 - Hryhorenko; Eric ; et al. | 2014-02-27 |
| Methods and Intermediates for the Preparation of Optionally Radio-Labeled Imatinib App 20120316338 - Salter; Rhys ; et al. | 2012-12-13 |
| Certain substituted spirocyclic lactams and use thereof as pharmaceuticals Grant 7,655,686 - Auberson , et al. February 2, 2 | 2010-02-02 |
| Methods And Intermediates For The Preparation Of Optionally Radio-labeled Imatinib App 20090299064 - Salter; Rhys ; et al. | 2009-12-03 |
| Certain substituted spirocyclic lactams and use thereof as pharmaceuticals App 20070265328 - Auberson; Yves ; et al. | 2007-11-15 |
| Certain substituted spirocyclic lactams and use thereof as pharmaceuticals App 20070015781 - Auberson; Yves ; et al. | 2007-01-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 